|
[1]LINDENMEYER CC, Mc CULLOUGH AJ.The natural history of nonalcoholic fatty liver disease-an evolving view[J].Clin Liver Dis, 2018, 22 (1) :11-21.
|
|
[2]FAN JG, ZHU J, LI XJ, et al.Prevalence of and risk factors for fatty liver in a general population of Shanghai, China[J].J Hepatol, 2005, 43 (3) :508-514.
|
|
[3]HASHIMOTO E, TANIAI M, TOKUSHIGE K.Characteristics and diagnosis of NAFLD/NASH[J].J Gastroenterol Hepatol, 2013, 28 (Suppl 4) :64-70.
|
|
[4]THAN NN, NEWSOME PN.A concise review of non-alcoholic fatty liver disease[J].Atherosclerosis, 2015, 239 (1) :192-202.
|
|
[5]SWEET PH, KHOO T, NGUYEN S.Nonalcoholic fatty liver disease[J].Prim Care, 2017, 44 (4) :599-607.
|
|
[6]ARGO CK, NORTHUP PG, AL-OSAIMI AM, et al.Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis[J].J Hepatol, 2009, 51 (2) :371-379.
|
|
[7]ANGULO P.Long-term mortality in nonalcoholic fatty liver disease:is liver histology of any prognostic significance?[J].Hepatology, 2010, 51 (2) :373-375.
|
|
[8]STANKOVIC'MN, MLADENOVIC'DR, DURICˇIC'I, et al.Time-dependent changes and association between liver free fatty acids, serum lipid profile and histological features in mice model of nonalcoholic fatty liver disease[J].Arch Med Res, 2014, 45 (2) :116-124.
|
|
[9]CHENG JY, WONG VW, TSE YK, et al.Metabolic syndrome increases cardiovascular events but not hepatic events and death in patients with chronic hepatitis B[J].Hepatology, 2016, 64 (5) :1507-1517.
|
|
[10]DAM-LARSEN S, BECKER U, FRANZMANN MB, et al.Final results of a long-term, clinical follow-up in fatty liver patients[J].Scand J Gastroenterol, 2009, 44 (10) :1236-1243.
|
|
[11]TILG H, MOSCHEN AR.Evolution of inflammation in nonalcoholic fatty liver disease:the multiple parallel hits hypothesis[J].Hepatology, 2010, 52 (5) :1836-1846.
|
|
[12]TREEPRASERTSUK S, LOPEZ-JIMENEZ F, LINDOR KD.Nonalcoholic fatty liver disease and the coronary artery disease[J].Dig Dis Sci, 2011, 56 (1) :35-45.
|
|
[13]DAY CP, JAMES OF.Steatohepatitis:a tale of two"hits"?[J].Gastroenterology, 1998, 114 (4) :842-845.
|
|
[14]PAPPACHAN JM, BABU S, KRISHNAN B, et al.Non-alcoholic fatty liver disease:a clinical update[J].J Clin Transl Hepatol, 2017, 5 (4) :384-393.
|
|
[15]SANYAL AJ, American Gastroenterological Association.AGA technical review on nonalcoholic fatty liver disease[J].Gastroenterology, 2002, 123 (5) :1705-1725.
|
|
[16]CHALASANI N, YOUNOSSI Z, LAVINE JE, et al.The diagnosis and management of non-alcoholic fatty liver disease:practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association[J].Hepatology, 2012, 55 (6) :2005-2023.
|
|
[17]SCHINDHELM RK, HEINE RJ, DIAMANT M.Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients[J].Diabetes Care, 2007, 30 (9) :e94.
|
|
[18]REID AE.Nonalcoholic steatohepatitis[J].Gastroenterology, 2001, 121 (3) :710-723.
|
|
[19]TSAI E, LEE TP.Diagnosis and evaluation of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis, including noninvasive biomarkers and transient elastography[J].Clin Liver Dis, 2018, 22 (1) :73-92.
|
|
[20]TAKEUCHI H, SUGIMOTO K, OSHIRO H, et al.Liver fibrosis:noninvasive assessment using supersonic shear imaging and FIB4 index in patients with non-alcoholic fatty liver disease[J].J Med Ultrason (2001) , 2017.[Epub ahead of print]
|
|
[21]HWANG YC, AHN HY, PARK SW, et al.Non-alcoholic fatty liver disease associates with increased overall mortality and death from cancer, cardiovascular disease, and liver disease in women but not men[J].Clin Gastroenterol Hepatol, 2017.[Epub ahead of print]
|
|
[22]TASNEEM AA, LUCK NH, MAJID Z.Factors predicting non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) [J].Trop Doct, 2017.[Epub ahead of print]
|
|
[23]HASHIMOTO E, YATSUJI S, TOBARI M, et al.Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis[J].J Gastroenterol, 2009, 44 (Suppl 19) :89-95.
|
|
[24]VILAR-GOMEZ E, CHALASANI N.Noninvasive assessment of nonalcoholic fatty liver disease:clinical prediction rules and blood based biomarkers[J].J Hepatol, 2017.[Epub ahead of print]
|
|
[25]YATSUJI S, HASHIMOTO E, TOBARI M, et al.Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C[J].J Gastroenterol Hepatol, 2009, 24 (2) :248-254.
|
|
[26]BYRNE CD, TARGHER G.NAFLD:a multisystem disease[J].J Hepatol, 2015, 62 (1 Suppl) :s47-s64.
|
DownLoad: